山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (2): 7-14.doi: 10.6040/j.issn.1673-3770.0.2021.318

• • 上一篇    下一篇

中耳间变性大T细胞淋巴瘤1例并文献复习

赵笑冰,张大为,陈仁杰   

  1. 南京医科大学第二附属医院 耳鼻咽喉头颈外科, 江苏 南京 210000
  • 发布日期:2022-04-15
  • 通讯作者: 陈仁杰. E-mail:renjiechenent@aliyun.com
  • 基金资助:
    江苏省青年医学人才项目(QNRC2016679)

A case of middle-ear anaplastic large T- cell lymphoma and literature review

ZHAO Xiaobing,ZHANG Dawei, CHEN Renjie   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu, China
  • Published:2022-04-15

PDF (PC)

250

摘要： 目的 探讨中耳间变性大T细胞淋巴瘤的临床特点及诊疗方法,以便对其进行早期诊断。 方法 回顾性分析1例中耳间变性大T细胞淋巴瘤患者的临床资料并复习相关文献进行总结。 结果 淋巴瘤多发生于骨骼、骨髓、皮下组织和脾脏,发生于中耳者罕见。中耳淋巴瘤起病时均无浅表淋巴结肿大,通常表现为耳痛、听力下降及耳内溢液(浆液性、脓性或血性),病情进展,可出现周围性面瘫及颅内外并发症。CT影像学表现可见软组织密度较高且不均匀,骨质破坏不规则、呈虫蚀样,病变范围广,增强扫描可见强化明显。确诊需病理活检及免疫组化,以化学治疗为主。 结论 中耳间变性大T细胞淋巴瘤极为罕见,且临床及影像学表现无特异性,因而详细的病史采集、全身系统检查、病理活检及免疫组化等手段对于早期诊断疾病非常重要。

关键词: 中耳, 肿瘤, 间变性大T细胞淋巴瘤, 免疫组合化学, 耳外科手术

Abstract: Objective To investigate the clinical characteristics, diagnosis and treatment methods of middle ear anaplastic large T-cell lymphoma, to enable its early diagnosis. Methods A patient with middle ear anaplastic large T-cell lymphoma was retrospectively reviewed,along with previous cases of middle ear lymphoma found in the literature. Results Lymphoma mostly occurs in the bones, bone marrow, subcutaneous tissue and spleen, but rarely in the middle ear. There is no superficial lymphadenopathy at the onset of middle ear lymphoma, which usually presents as earache, hearing loss, and ear discharge(serous, purulent, or bloody). Disease progression, peripheral facial nerve paralysis and extra cranial-intracranial complications may occur. The lesion appeared as a high and uneven soft tissue density on the CT and the bone destruction was irregular and worm-eaten. The lesion area was wide and the enhanced scan showed obvious enhancement. Diagnosis requires pathological biopsy and immunohistochemistry. Chemotherapy is the main treatment. Conclusion Middle ear anaplastic large T-cell lymphoma is extremely rare and its clinical and imaging findings are non-specific. Therefore it is imperative to carefully consider the patient’s medical history, systemic examination findings, pathological biopsy findings and immunohistochemistry to diagnose middle ear anaplastic large T-cell lymphoma at an early stage.

Key words: Middle ear, Tumor, Anaplastic large T cell lymphoma, Immunocombination chemistry, Otology surgery

中图分类号: 

  • R764.92
[1] 文锋, 王冰洁, 扈希昊, 等. 咽淋巴环套细胞淋巴瘤4例及文献复习[J]. 山东大学耳鼻喉眼学报, 2020,34(1): 115-120. doi: 10.6040/j.issn.1673-3770.0.2019.490. WEN Feng, WANG Bingjie, HU Xihao, et al. Mantle cell lymphoma involving the Waldeyer's ring: a case series and literature review[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(1): 115-120. doi: 10.6040/j.issn.1673-3770.0.2019.490.
[2] 杨国溜, 陈良远, 欧巧萍. 外周血EB病毒DNA与非霍奇金淋巴瘤的预后相关性研究[J]. 国际检验医学杂志, 2020,41(3): 290-292,296. doi: CNKI:SUN:GWSQ.0.2020-03-009. YANG Guoliu, CHEN Liangyuan, OU Qiaoping. Study on the relationship between Epstein-Barr virus DNA and prognosis of non-Hodgkin's lymphoma[J]. Int J Lab Med, 2020,41(3): 290-292,296. doi: CNKI:SUN:GWSQ.0.2020-03-009.
[3] Chihara D, Fanale MA. Management of anaplastic large cell lymphoma[J]. Hematol Oncol Clin North Am, 2017, 31(2): 209-222. doi:10.1016/j.hoc.2016.11.001.
[4] Al-Hamadani M, Habermann TM, Cerhan JR, et al. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011[J]. Am J Hematol, 2015, 90(9): 790-795. doi:10.1002/ajh.24086.
[5] Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States[J]. J Clin Oncol, 2016, 34(9): 963-971. doi:10.1200/JCO.2015.63.5540.
[6] Box JK, Paquet N, Adams MN, et al. Nucleophosmin: from structure and function to disease development[J]. BMC Mol Biol, 2016, 17(1): 19. doi:10.1186/s12867-016-0073-9.
[7] Montes-Mojarro IA, Steinhilber J, Bonzheim I, et al. The pathological spectrum of systemic anaplastic large cell lymphoma(ALCL)[J]. Cancers(Basel), 2018, 10(4): E107. doi:10.3390/cancers10040107.
[8] Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20): 2375-2390. doi:10.1182/blood-2016-01-643569.
[9] Mora J, Filippa DA, Thaler HT, et al. Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center[J]. Cancer, 2000, 88(1): 186-197. doi:10.1002/(sici)1097-0142(20000101)88: 1<186: aid-cncr26>3.0.co;2-5.
[10] Stein H, Foss HD, Dürkop H, et al. CD30(+)anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features[J]. Blood, 2000, 96(12): 3681-3695. doi: 10.1053/beha.2000.0100.
[11] King RL, Dao LD, McPhail ED, et al. Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements[J]. Am J Surg Pathol, 2016, 40(1): 36-43. doi:10.1097/PAS.0000000000000500.
[12] Shustov A, Soma L. Anaplastic large cell lymphoma: contemporary concepts and optimal management[J]. Cancer Treat Res, 2019, 176: 127-144. doi:10.1007/978-3-319-99716-2_6.
[13] Agnelli L, Mereu E, Pellegrino E, et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma[J]. Blood, 2012, 120(6): 1274-1281. doi:10.1182/blood-2012-01-405555.
[14] Pedersen MB, Hamilton-Dutoit SJ, Bendix K, et al. Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry[J]. Hematol Oncol, 2015, 33(4): 120-128. doi:10.1002/hon.2153.
[15] 陈英坤, 俞文娟, 刘辉, 等. 原发系统型间变性大细胞淋巴瘤40例临床特征及预后分析[J]. 中华血液学杂志, 2020(3): 222-227. doi: 10.3760/cma.j.issn.0253-2727.2020.03.007. Chen Yingkun, Yu Wenjuan, Liu Hui, et al. Clinical features and prognosis analysis of 40 cases of primary systemic anaplastic large cell lymphoma[J]. Chinese Journal of Hematology, 2020(3): 222-227. doi: 10.3760/cma.j.issn.0253-2727.2020.03.007.
[16] Allen CE, Kelly KM, Bollard CM. Pediatric lymphomas and histiocytic disorders of childhood[J]. Pediatr Clin North Am, 2015, 62(1): 139-165. doi:10.1016/j.pcl.2014.09.010.
[17] Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project[J]. Blood, 2008, 111(12): 5496-5504. doi:10.1182/blood-2008-01-134270.
[18] Ceccon M, Merlo MEB, Mologni L, et al. Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency[J]. Oncogene, 2016, 35(29): 3854-3865. doi:10.1038/onc.2015.456.
[19] Zeng Y, Feldman AL. Genetics of anaplastic large cell lymphoma[J]. Leuk Lymphoma, 2016, 57(1): 21-27. doi:10.3109/10428194.2015.1064530.
[20] Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma[J]. Blood, 2015, 126(1): 17-25. doi:10.1182/blood-2014-10-567461.
[21] 何健, 钱立庭, 高劲. 外耳道腺样囊性癌侵犯中耳、颞叶且伴颈部淋巴结转移一例报告[J]. 山东大学耳鼻喉眼学报, 2018,32(6): 109-111,118. doi: 10.6040/j.issn.1673-3770.0.2017.424. HE Jian, QIAN Liting, GAO Jin. A case of external auditory canal adenoid cystic carcinoma invading the middle ear and temporal lobe, with cervical lymph node metastasis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018,32(6): 109-111,118. doi: 10.6040/j.issn.1673-3770.0.2017.424.
[22] Thakral B, Zhou J, Medeiros LJ. Extranodal hematopoietic neoplasms and mimics in the head and neck: an update[J]. Hum Pathol, 2015, 46(8): 1079-1100. doi:10.1016/j.humpath.2015.05.007.
[23] Alqunaee M, Aldaihani A, AlHajery M. Non-Hodgkin's lymphoma of the middle ear presenting as mastoiditis[J]. Case Rep Otolaryngol, 2018, 2018: 7639784. doi:10.1155/2018/7639784.
[24] 孟琳, 姜妍, 余晔. 中耳恶性淋巴瘤一例[J]. 听力学及言语疾病杂志, 2020,28(6): 725-727. doi: 10.3969/j.issn.1006-7299.2020.06.027.
[25] Tram Do B, Charpentier AM, Bourré-Tessier J, et al. Unusual presentation for small lymphocytic lymphoma: Case report of a man with bilateral ear involvement and review of the literature[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2019, 136(3S): S45-S47. doi:10.1016/j.anorl.2018.10.017.
[26] Danino J, Joachims HZ, Ben-Arieh Y, et al. T cell lymphoma of the ear presenting as mastoiditis[J]. J Laryngol Otol, 1997, 111(9): 852-854. doi:10.1017/s0022215100138794.
[27] Li B, Liu SX, Yang H, et al. Primary T-cell lymphoblastic lymphoma in the middle ear[J]. Int J Pediatr Otorhinolaryngol, 2016, 82: 19-22. doi:10.1016/j.ijporl.2015.12.020.
[28] Jain P, Fayad LE, Rosenwald A, et al. Recent advances in de novo CD5+diffuse large B cell lymphoma[J]. Am J Hematol, 2013, 88(9): 798-802. doi:10.1002/ajh.23467.
[29] Hart S, Horsman JM, Radstone CR, et al. Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience(1971-2000)[J]. Clin Oncol(R Coll Radiol), 2004, 16(3): 186-192. doi:10.1016/j.clon.2003.10.010.
[30] Jackson R, Addison AB, Prinsley PR. Cholesteatoma in children and adults: are there really any differences?[J]. J Laryngol Otol, 2018, 132(7): 575-578. doi:10.1017/S0022215118000890.
[31] Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma[J]. J Int Adv Otol, 2017, 13(1): 1-8. doi:10.5152/iao.2017.3363.
[32] 杨扬, 肖潇, 陈敏, 等. 儿童中耳胆脂瘤JOS分期及其临床特征[J]. 山东大学耳鼻喉眼学报, 2019,33(05), 33: 52-55. doi: 10.6040/j.issn.1673-3770.0.2019.376. YANG Yang, XIAO Xiao, CHEN Min, et al. JOS staging and clinical features of middle ear cholesteatoma in children[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019,33(05), 33: 52-55. doi: 10.6040/j.issn.1673-3770.0.2019.376.
[33] Gomaa MA, Abdel Karim AR, Abdel Ghany HS, et al. Evaluation of temporal bone cholesteatoma and the correlation between high resolution computed tomography and surgical finding[J]. Clin Med Insights Ear Nose Throat, 2013, 6: 21-28. doi:10.4137/CMENT.S10681.
[34] Wallis S, Atkinson H, Coatesworth A P. Chronic otitis media[J]. Postgrad Med, 2015, 127(4): 391-395. doi: 10.1080/00325481.2015.1027133.
[35] Jaisinghani VJ, Paparella MM, Schachern PA, et al. Tympanic membrane/middle ear pathologic correlates in chronic otitis media[J]. Laryngoscope, 1999, 109(5): 712-716. doi:10.1097/00005537-199905000-00007.
[36] 杨昌秀. 46例中耳胆脂瘤的临床特征及手术疗效分析[J]. 现代临床医学, 2020, 46(6): 425-428. doi:10.11851/j.issn.1673-1557.2020.06.009. YANG Changxiu. Clinicalfeature and operative effect of 46 cases of middle ear of cholesteatoma[J]. J Mod Clin Med, 2020, 46(6): 425-428. doi:10.11851/j.issn.1673-1557.2020.06.009.
[37] Ayache D, Darrouzet V, Dubrulle F, et al. Imaging of non-operated cholesteatoma: clinical practice guidelines[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2012, 129(3): 148-152. doi:10.1016/j.anorl.2011.09.005.
[38] Mileshina NA, Kurbatova EV. Cholesteatoma of the external and middle ear in the childhood[J]. Vestn Otorinolaringol, 2015(1): 25-27. doi:10.17116/otorino201580125-27.
[39] Yates PD, Flood LM, Banerjee A, et al. CT scanning of middle ear cholesteatoma: what does the surgeon want to know?[J]. Br J Radiol, 2002, 75(898): 847-852. doi:10.1259/bjr.75.898.750847.
[40] Mittal R, Lisi CV, Gerring R, et al. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media[J]. J Med Microbiol, 2015, 64(10): 1103-1116. doi:10.1099/jmm.0.000155.
[41] Filipe M, Reimer Å, Matuschek E, et al. Fluoroquinolone-resistant Alcaligenes faecalis related to chronic suppurative otitis media, Angola[J]. Emerg Infect Dis, 2017, 23(10): 1740-1742. doi:10.3201/eid2310.170268.
[42] Varshney S, Nangia A, Bist SS, et al. Ossicular chain status in chronic suppurative otitis media in adults[J]. Indian J Otolaryngol Head Neck Surg, 2010, 62(4): 421-426. doi:10.1007/s12070-010-0116-3.
[43] Majeed J, Sudarshan Reddy L. Role of CT mastoids in the diagnosis and surgical management of chronic inflammatory ear diseases[J]. Indian J Otolaryngol Head Neck Surg, 2017, 69(1): 113-120. doi:10.1007/s12070-016-1023-z.
[44] Brennan-Jones CG, Head K, Chong LY, et al. Topical antibiotics for chronic suppurative otitis media[J]. Cochrane Database Syst Rev, 2020, 1: CD013051. doi:10.1002/14651858.CD013051.pub2.
[45] Gendeh HS, Abdullah AB, Goh BS, et al. Intracranial complications of chronic otitis media: why does it still occur?[J]. Ear Nose Throat J, 2019, 98(7): 416-419. doi:10.1177/0145561319840166.
[46] Ellin F, Landström J, Jerkeman M, et al. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study[J]. Blood, 2015, 126(1): 36-41. doi:10.1182/blood-2014-12-616961.
[47] 刘丁丁, 钱晓云, 刘永泽, 等. 84例原发头颈部淋巴瘤临床及病理特征分析[J]. 山东大学耳鼻喉眼学报, 2018,32(6): 48-51. doi: 10.6040/j.issn.1673-3770.0.2018.274. LIU Dingding, QIAN Xiaoyun, LIU Yongze, et al. Analysis of clinical and pathological features of 84 patients with primary head and neck lymphoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018,32(6): 48-51. doi: 10.6040/j.issn.1673-3770.0.2018.274.
[48] Cederleuf H, Bjerregård Pedersen M, Jerkeman M, et al. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: a Nordic Lymphoma Group study[J]. Br J Haematol, 2017, 178(5): 739-746. doi:10.1111/bjh.14740.
[49] Ganesan P, Joshua T, Sundersingh S, et al. Refractory ALK-positive anaplastic large cell lymphoma: long term survival with crizotinib[J]. Indian J Hematol Blood Transfus, 2018, 34(2): 353-354. doi:10.1007/s12288-017-0889-6.
[50] Vu K, Ai WY. Update on the treatment of anaplastic large cell lymphoma[J]. Curr Hematol Malig Rep, 2018, 13(2): 135-141. doi:10.1007/s11899-018-0436-z.
[51] Piccaluga PP, Fuligni F, de Leo A, et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study[J]. J Clin Oncol, 2013, 31(24): 3019-3025. doi:10.1200/JCO.2012.42.5611.
[52] Wilhelm M, Smetak M, Reimer P, et al. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation[J]. Blood Cancer J, 2016, 6(7): e452. doi:10.1038/bcj.2016.63.
[53] Dhawale TM, Shustov AR. Autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas: a histology-specific review[J]. Hematol Oncol Clin North Am, 2017, 31(2): 335-357. doi:10.1016/j.hoc.2016.11.003.
[54] Pro B, Advani R, Brice P, et al. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma[J]. Blood, 2017, 130(25): 2709-2717. doi:10.1182/blood-2017-05-780049.
[55] Lesokhin AM, Ansell SM, Armand P, et al. Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase ib study[J]. J Clin Oncol, 2016, 34(23): 2698-2704. doi:10.1200/jco.2015.65.9789.
[56] Shi Y, Jia B, Xu W, et al. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China[J]. J Hematol Oncol, 2017, 10(1): 69. doi:10.1186/s13045-017-0439-6.
[57] Amengual JE, Lichtenstein R, Lue J, et al. A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma[J]. Blood, 2018, 131(4): 397-407. doi:10.1182/blood-2017-09-806737.
[58] Horwitz S, O'Connor OA, Pro B, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma(ECHELON-2): a global, double-blind, randomised, phase 3 trial[J]. Lancet, 2019, 393(10168): 229-240. doi:10.1016/s0140-6736(18)32984-2.
[59] Ramos CA, Grover NS, Beaven AW, et al. Anti-CD30 CAR-T cell therapy in relapsed and refractory Hodgkin lymphoma[J]. J Clin Oncol, 2020, 38(32): 3794-3804. doi:10.1200/JCO.20.01342.
[1] 张国民,王茂华,高松,吴文斌,虞幼军. 持续灌流模式耳内镜下粘连性中耳炎手术疗效分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 16-19.
[2] 许亚琳,陈庆泳,王冬青,林立强,陈志鹏,吕怀庆. 耳后沟切口联合腮腺下极瓣修复在腮腺浅叶良性肿瘤手术中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 1-6.
[3] 彭中华,陈竹,袁洛花,余绍兰,马玉玲. 原发性鼻腔高级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 95-98.
[4] 胡祎,孔旭辉. 补体在喉鳞状细胞癌发生发展中作用机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 148-155.
[5] 王华,张丰珍,龙婷,赵靖,李宏彬,王生才,王桂香. 后颅窝肿瘤术后儿童气管切开原因及预后转归分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 168-173.
[6] 于浩南,钟莹莹,王新萌,张敏,姜清敏,李娜,李艳. TNF-α诱导的人脐带间充质干细胞培养基对小鼠角膜缘干细胞缺乏的治疗作用[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 141-147.
[7] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[8] 谢枫,许贞菊,吴策,刘杰,臧传善,张龙宵,韩敏. 喉神经内分泌肿瘤26例临床病理特征及生存分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 79-86.
[9] 黄佳丽,刘梓琪,徐娟,陈曦,张立庆,周涵. 咽部梭形细胞鳞状细胞癌的临床及预后分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 94-100.
[10] 宋瑾,尹慧,高娴,李永团. 坏死梭杆菌致成人中耳炎并发脑膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 96-100.
[11] 周莹,王刚,王磊,张晓丽,韩浩伦,李保卫,孙喆喆,吴玮. 咽喉反流相关中耳炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 131-135.
[12] 彭宇婷,李坚昊,王燕. 鼻-眼眶-颅底恶性肿瘤继发眶尖综合征1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 105-111.
[13] 杨煜雲,黄艳利,李军政. 铜配合物在抗肿瘤治疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 145-152.
[14] 林云仙,马玲国. 咽鼓管圆枕淀粉样变性伴中耳积液1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 86-90.
[15] 汪洋,胡越,李晓明,齐雯雯,张杰,张皓,王倩倩,许风雷,贾涛,夏明. 3D打印钛金属假体修复大面积气管缺损1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 121-125.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发